GT Apeiron Therapeutics Funding: $18M Raised, Series A

GT Apeiron Therapeutics is based in San Francisco Bay Area. It has raised $18M in total funding. Latest round: Series A.

GT Apeiron Therapeutics funding overview

GT Apeiron Therapeutics is based in San Francisco Bay Area. GT Apeiron Therapeutics has raised $18M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in January 1970. The round record for GT Apeiron Therapeutics runs through 1970; nothing later has been disclosed. Investors on record include Panacea Venture, Viva BioInnovator. 2 distinct backers are named across the disclosed rounds.

GT Apeiron Therapeutics at a glance

Total raised
$18M
Latest round
Series A
Latest round date
January 1970
Headquarters
San Francisco Bay Area
Notable investors
Panacea Venture, Viva BioInnovator

Frequently asked about GT Apeiron Therapeutics funding

How much has GT Apeiron Therapeutics raised?
GT Apeiron Therapeutics has raised $18M in total disclosed funding across the rounds on record.
Who has invested in GT Apeiron Therapeutics?
Panacea Venture, Viva BioInnovator are named among the investors backing GT Apeiron Therapeutics.
What was the latest GT Apeiron Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 1970.
Where is GT Apeiron Therapeutics based?
GT Apeiron Therapeutics is based in San Francisco Bay Area.
When did GT Apeiron Therapeutics last raise?
The last disclosed GT Apeiron Therapeutics round closed in January 1970 at Series A.

Every GT Apeiron Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Francisco Bay Area at a similar stage.

Companies related to GT Apeiron Therapeutics (27)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026